DYN•benzinga•
Oppenheimer Assumes Dyne Therapeutics at Outperform, Lowers Price Target of $34
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 2, 2025 by benzinga